Leukapheresis Does Not Improve Early Survival Outcome of Acute Myeloid Leukemia with Leukostasis Patients - A Dual-Center Retrospective Cohort Study.

Ikhwan RinaldiResti Mulya SariVanya Utami TedhyKevin Winston

Published in: Journal of blood medicine (2021)

AML patients with leukostasis who received both chemotherapy and leukapheresis did not have better 28-day survival and 7-day survival when compared with patients receiving chemotherapy only. Old age, high blast percentage, high creatinine, and presence of disseminated intravascular coagulation were prognostic factors for worse 28-day survival.

Keyphrases

prognostic factors
acute myeloid leukemia
end stage renal disease
free survival
chronic kidney disease
allogeneic hematopoietic stem cell transplantation
squamous cell carcinoma
peritoneal dialysis
coronary artery